Competitive learning suggests circulating miRNA profiles for cancers decades prior to diagnosis

References

• He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5(7):522–531.
   PubMed Web of Science ®Google Scholar
• Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116(2):281–297.
   PubMed Web of Science ®Google Scholar
• Hart M, Kern F, Backes C, et al. The deterministic role of 5-mers in microRNA-gene targeting. RNA Biol. 2018;15(6):819–825.
   PubMed Web of Science ®Google Scholar
• Lu J, Getz G, Miska EA, et al. MicroRNA expression profiles classify human cancers. Nature. 2005;435(7043):834–838.
   PubMed Web of Science ®Google Scholar
• Maciotta S, Meregalli M, Torrente Y. The involvement of microRNAs in neurodegenerative diseases. Front Cell Neurosci. 2013;7:265.
   PubMed Web of Science ®Google Scholar
• Backes C, Meese E, Keller A. Specific miRNA disease biomarkers in blood, serum and plasma: challenges and prospects. Mol Diagn Ther. 2016;20(6):509–518.
   PubMed Web of Science ®Google Scholar
• Fehlmann T, Ludwig N, Backes C, et al. Distribution of microRNA biomarker candidates in solid tissues and body fluids. RNA Biol. 2016;13(11):1084–1088.
   PubMed Web of Science ®Google Scholar
• Hjerkind KV, Gislefoss RE, Tretli S, et al. cohort profile update: the janus serum bank cohort in Norway. Int J Epidemiol. 2017;46(4):1101–2f.
   PubMed Web of Science ®Google Scholar
• Jellum E, Andersen A, Lund-Larsen P, et al. The JANUS serum bank. Sci Total Environ. 1993;139-140:527–535.
   PubMed Web of Science ®Google Scholar
• Gislefoss RE, Grimsrud TK, Morkrid L. Long-term stability of serum components in the Janus Serum Bank. Scand J Clin Lab Invest. 2008;68(5):402–409.
   PubMed Web of Science ®Google Scholar
• Langseth H, Gislefoss RE, Martinsen JI, et al. Cohort profile: the janus serum bank cohort in Norway. Int J Epidemiol. 2017;46(2):403–4g.
   PubMed Web of Science ®Google Scholar
• Fehlmann T, Backes C, Alles J, et al. A high-resolution map of the human small non-coding transcriptome. Bioinformatics. 2018;34(10):1621–1628.
   PubMed Web of Science ®Google Scholar
• Keller A, Leidinger P, Vogel B, et al. miRNAs can be generally associated with human pathologies as exemplified for miR-144. BMC Med. 2014;12(1):224.
   PubMedGoogle Scholar
• Keller A, Leidinger P, Bauer A, et al. Toward the blood-borne miRNome of human diseases. Nat Methods. 2011;8(10):841–843.
   PubMed Web of Science ®Google Scholar
• Alles J, Fehlmann T, Fischer U, et al. An estimate of the total number of true human miRNAs. Nucleic Acids Res. 2019;47(7):3353–3364.
   PubMed Web of Science ®Google Scholar
• Keller A, Meese E. Can circulating miRNAs live up to the promise of being minimal invasive biomarkers in clinical settings? Wiley Interdiscip Rev RNA. 2016;7(2):148–156.
   PubMed Web of Science ®Google Scholar
• Keller A, Rounge T, Backes C, et al. Sources to variability in circulating human miRNA signatures. RNA Biol. 2017;14(12):1791–1798.
   PubMed Web of Science ®Google Scholar
• Rounge TB, Umu SU, Keller A, et al. Circulating small non-coding RNAs associated with age, sex, smoking, body mass and physical activity. Sci Rep. 2018;8(1):17650.
   PubMedGoogle Scholar
• Keller A, Leidinger P, Gislefoss R, et al. Stable serum miRNA profiles as potential tool for non-invasive lung cancer diagnosis. RNA Biol. 2011;8(3):506–516.
   PubMed Web of Science ®Google Scholar
• Umu SU, Langseth H, Keller A, et al. A 10-year prediagnostic follow-up study shows that serum RNA signals are highly dynamic in lung carcinogenesis. Mol Oncol. 2020;14(2):235–247.
   PubMed Web of Science ®Google Scholar
• Baglietto L, Ponzi E, Haycock P, et al. DNA methylation changes measured in pre-diagnostic peripheral blood samples are associated with smoking and lung cancer risk. Int J Cancer. 2017;140:50–61.
   PubMed Web of Science ®Google Scholar
• Fasanelli F, Baglietto L, Ponzi E, et al. Hypomethylation of smoking-related genes is associated with future lung cancer in four prospective cohorts. Nat Commun. 2015;6(1):10192.
   PubMedGoogle Scholar
• Meng S, De Vivo I, Liang L, et al. Pre-diagnostic leukocyte mitochondrial DNA copy number and risk of lung cancer. Oncotarget. 2016;7(19):27307–27312.
   PubMedGoogle Scholar
• Dai L, Tsay JC, Li J, et al. Autoantibodies against tumor-associated antigens in the early detection of lung cancer. Lung Cancer. 2016;99:172–179.
   PubMed Web of Science ®Google Scholar
• Zhou B, Shu B, Yang J, et al. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis. Cancer Causes Control. 2014;25(10):1397–1405.
   PubMed Web of Science ®Google Scholar
• Touvier M, Fezeu L, Ahluwalia N, et al. Pre-diagnostic levels of adiponectin and soluble vascular cell adhesion molecule-1 are associated with colorectal cancer risk. World J Gastroenterol. 2012;18(22):2805–2812.
   PubMed Web of Science ®Google Scholar
• Opstal-van Winden AW, Krop EJ, Karedal MH, et al. Searching for early breast cancer biomarkers by serum protein profiling of pre-diagnostic serum; a nested case-control study. BMC Cancer. 2011;11(1):381.
   PubMedGoogle Scholar
• Trabert B, Pinto L, Hartge P, et al. Pre-diagnostic serum levels of inflammation markers and risk of ovarian cancer in the prostate, lung, colorectal and ovarian cancer (PLCO) screening trial. Gynecol Oncol. 2014;135(2):297–304.
   PubMed Web of Science ®Google Scholar
• Kohonen T. Self-organized formation of topologically correct feature maps. Biol Cybern. 1982;43(1):59–69.
   Web of Science ®Google Scholar
• Meder B, Backes C, Haas J, et al. Influence of the confounding factors age and sex on microRNA profiles from peripheral blood. Clin Chem. 2014;60(9):1200–1208.
   PubMed Web of Science ®Google Scholar
• Ludwig N, Hecksteden A, Kahraman M, et al. Spring is in the air: seasonal profiles indicate vernal change of miRNA activity. RNA Biol. 2019;16(8):1034–1043.
   PubMed Web of Science ®Google Scholar
• ElSharawy A, Keller A, Flachsbart F, et al. Genome-wide miRNA signatures of human longevity. Aging Cell. 2012;11(4):607–616.
   PubMed Web of Science ®Google Scholar
• Nagy ZB, Barták BK, Kalmár A, et al. Comparison of circulating miRNAs expression alterations in matched tissue and plasma samples during colorectal cancer progression. Pathol Oncol Res. 2019;25(1):97–105.
   PubMed Web of Science ®Google Scholar
• Usuba W, Urabe F, Yamamoto Y, et al. Circulating miRNA panels for specific and early detection in bladder cancer. Cancer Sci. 2019;110(1):408–419.
   PubMed Web of Science ®Google Scholar
• Zhang Y, Kang R, Liu W, et al. Identification and analysis of P53-mediated competing endogenous RNA network in human hepatocellular carcinoma. Int J Biol Sci. 2017;13(9):1213–1221.
   PubMed Web of Science ®Google Scholar
• Zaporozhchenko IA, Ponomaryova AA, Rykova EY, et al. The potential of circulating cell-free RNA as a cancer biomarker: challenges and opportunities. Expert Rev Mol Diagn. 2018;18(2):133–145.
   PubMed Web of Science ®Google Scholar
• Fitzgerald RC. Big data is crucial to the early detection of cancer. Nat Med. 2020;26(1):19–20.
   PubMed Web of Science ®Google Scholar
• Fehlmann T, Kahraman M, Ludwig N, et al. Evaluating the use of circulating MicroRNA profiles for lung cancer detection in symptomatic patients. JAMA Oncol. 2020;6(5):714.
   PubMed Web of Science ®Google Scholar
• Blondal T, Jensby Nielsen S, Baker A, et al. Assessing sample and miRNA profile quality in serum and plasma or other biofluids. Methods. 2013;59(1):S1–6.
   PubMed Web of Science ®Google Scholar
• Backes C, Khaleeq QT, Meese E, et al. miEAA: microRNA enrichment analysis and annotation. Nucleic Acids Res. 2016;44(W1):W110–6.
   PubMed Web of Science ®Google Scholar